Showing results (291-300 of 566) with videos related to
Sort By:
Pageof 57
Cancer|November 15, 2007
Prospective analysis of carotid artery flow in breast cancer patients treated with supraclavicular irradiation 8 or more years previously: no increase in ipsilateral carotid stenosis after radiation notedWendy A Woodward, Jean B Durand, Susan L Tucker, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2015
Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survivalDaniel R Gomez, Kai-Ping Liao, Stephen G Swisher, et al.Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
Human vitamin B12 absorption measurement by accelerator mass spectrometry using specifically labeled (14)C-cobalaminColleen Carkeet, Stephen R Dueker, Jozsef Lango, et al.International Journal of Radiation Oncology, Biology, Physics|April 2, 2016
Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy ReformShervin M Shirvani, Jing Jiang, Anna Likhacheva, et al.Journal of Cardiovascular Pharmacology|October 1, 1992
Hemodynamic and renal effects of the protein kinase inhibitor staurosporine in conscious ratsR L Dundore, A C Brousseau, P G Habeeb, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2005
Cardiac morbidity of adjuvant radiotherapy for breast cancerDebra A Patt, James S Goodwin, Yong-Fang Kuo, et al.The Breast Journal|July 15, 2010
Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved OutcomeShaheenah Dawood, Yun Gong, Kristine Broglio, et al.Cancer Medicine|October 31, 2014
Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefitUma Raju, David P Molkentine, David R Valdecanas, et al.Head & Neck|November 15, 2012
Evaluating the impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated for oral cancers: a SEER-Medicare analysisBeth M Beadle, Kai-Ping Liao, Mark S Chambers, et al.Proceedings of the National Academy of Sciences of the United States of America|June 10, 2014
GABAA receptor target of tetramethylenedisulfotetramineChunqing Zhao, Sung Hee Hwang, Bruce A Buchholz, et al.Pageof 57